Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

346 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Genotyping/Phenotyping Approach with Careful Clinical Monitoring to Manage the Fluoropyrimidines-Based Therapy: Clinical Cases and Systematic Review of the Literature.
Conti V, De Bellis E, Manzo V, Sabbatino F, Iannello F, Dal Piaz F, Izzo V, Charlier B, Stefanelli B, Torsiello M, Iannaccone T, Coglianese A, Colucci F, Pepe S, Filippelli A. Conti V, et al. Among authors: pepe s. J Pers Med. 2020 Sep 3;10(3):113. doi: 10.3390/jpm10030113. J Pers Med. 2020. PMID: 32899374 Free PMC article. Review.
PD-L1 Dysregulation in COVID-19 Patients.
Sabbatino F, Conti V, Franci G, Sellitto C, Manzo V, Pagliano P, De Bellis E, Masullo A, Salzano FA, Caputo A, Peluso I, Zeppa P, Scognamiglio G, Greco G, Zannella C, Ciccarelli M, Cicala C, Vecchione C, Filippelli A, Pepe S. Sabbatino F, et al. Among authors: pepe s. Front Immunol. 2021 Jun 7;12:695242. doi: 10.3389/fimmu.2021.695242. eCollection 2021. Front Immunol. 2021. PMID: 34163490 Free PMC article.
Immune checkpoint inhibitors for the treatment of melanoma.
Sabbatino F, Liguori L, Pepe S, Ferrone S. Sabbatino F, et al. Among authors: pepe s. Expert Opin Biol Ther. 2022 May;22(5):563-576. doi: 10.1080/14712598.2022.2038132. Epub 2022 Feb 13. Expert Opin Biol Ther. 2022. PMID: 35130816 Free PMC article. Review.
Immune Checkpoint Inhibitors in Melanoma and HIV Infection.
Marra A, Scognamiglio G, Peluso I, Botti G, Fusciello C, Filippelli A, Ascierto PA, Pepe S, Sabbatino F. Marra A, et al. Among authors: pepe s. Open AIDS J. 2017 Nov 14;11:91-100. doi: 10.2174/1874613601711010091. eCollection 2017. Open AIDS J. 2017. PMID: 29290886 Free PMC article. Review.
Multidisciplinary approach to patient with malignant melanoma.
Scarpati GD, Fusciello C, Sabbatino F, Ferrone S, Caponigro F, Perri F, Carlomagno C, Pepe S. Scarpati GD, et al. Among authors: pepe s. Anticancer Agents Med Chem. 2013 Jul 1;13(6):887-900. doi: 10.2174/18715206113139990079. Anticancer Agents Med Chem. 2013. PMID: 23272971
Ipilimumab in the treatment of metastatic melanoma: management of adverse events.
Della Vittoria Scarpati G, Fusciello C, Perri F, Sabbatino F, Ferrone S, Carlomagno C, Pepe S. Della Vittoria Scarpati G, et al. Among authors: pepe s. Onco Targets Ther. 2014 Feb 19;7:203-9. doi: 10.2147/OTT.S57335. eCollection 2014. Onco Targets Ther. 2014. PMID: 24570590 Free PMC article. Review.
Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A, Ferrone CR, Fusciello C, Scognamiglio G, Ferrone S, Pepe S, Perri F, Sabbatino F. Marra A, et al. Among authors: pepe s. Anticancer Agents Med Chem. 2018;18(2):166-181. doi: 10.2174/1871520618666171219115335. Anticancer Agents Med Chem. 2018. PMID: 29256359 Review.
346 results